Education
About Us
Working with TipRanks
Follow Us
Genetic Technologies (AU:GTG)
ASX:GTG
RESEARCH TOOLSreports
GTG Stock Chart & Stats
Day’s Range― - ―
52-Week RangeAU$0.04 - AU$0.13
Previous CloseN/A
Volume10.07K
Average Volume (3M)0.00
Market Cap
$5.67M
Enterprise ValueN/A
Total Cash (Recent Filing)$1.02M
Total Debt (Recent Filing)AU$875.19K
Price to Earnings (P/E)―
Beta1.82
Next Earnings
Aug 28, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.10
Shares Outstanding1,335,422,500
10 Day Avg. Volume0
30 Day Avg. Volume0
Financial Highlights & Ratios
PEG Ratio-0.02
Price to Book (P/B)3.18
Price to Sales (P/S)0.00
P/FCF Ratio-0.99
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Genetic Technologies News
PremiumCompany Announcements
Genetic Technologies Announces Quotation of Over 1.16 Billion Securities
PremiumCompany Announcements
Genetic Technologies Expands Market Presence with New Securities Quotation
PremiumCompany Announcements
Genetic Technologies Announces Change of Office Locations
PremiumCompany Announcements
Director Departure at Genetic Technologies LimitedPremiumCompany Announcements
Genetic Technologies Announces Key Leadership Changes
PremiumCompany Announcements
Genetic Technologies Exits Administration and Establishes Creditors’ Trust
PremiumCompany Announcements
Genetic Technologies Announces New Director Appointment
PremiumCompany Announcements
Genetic Technologies Announces New Securities Issue to Boost CapitalGTG FAQ
What was Genetic Technologies’s price range in the past 12 months?
Genetic Technologies lowest share price was AU$0.04 and its highest was AU$0.13 in the past 12 months.
What is Genetic Technologies’s market cap?
Genetic Technologies’s market cap is $5.67M.
When is Genetic Technologies’s upcoming earnings report date?
Genetic Technologies’s upcoming earnings report date is Aug 28, 2025 which is in 91 days.
How were Genetic Technologies’s earnings last quarter?
Currently, no data Available
Is Genetic Technologies overvalued?
According to Wall Street analysts Genetic Technologies’s price is currently Overvalued.
Does Genetic Technologies pay dividends?
Genetic Technologies does not currently pay dividends.
What is Genetic Technologies’s EPS estimate?
Genetic Technologies’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Genetic Technologies have?
Genetic Technologies has 1,335,422,500 shares outstanding.
What happened to Genetic Technologies’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Genetic Technologies?
Currently, no hedge funds are holding shares in AU:GTG
Genetic Technologies Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Blogger Sentiment
Bearish
AU:GTG Sentiment 100%
Sector Average 70%
Sector Average 70%
News Sentiment
Neutral
Bullish news 50%
Bearish news 100%
Bearish news 100%
Fundamentals
Return on Equity
-181.97%
Trailing 12-Months
Asset Growth
-58.22%
Trailing 12-Months
Company Description
Genetic Technologies
Genetic Technologies (GTG) is a biotechnology company focused on the development and commercialization of genetic testing and risk assessment products. Operating within the healthcare and biotechnology sectors, the company offers a range of predictive genetic tests that help in assessing an individual's risk of developing certain diseases, with a particular focus on cancer and other complex disorders. GTG leverages advanced genomic technologies to provide personalized insights, enabling improved healthcare outcomes through early risk detection and prevention strategies.
Technical Analysis
Resonance Health Ltd
―
Race Oncology Ltd.
―
Australian Clinical Labs Ltd
―
Botanix Pharmaceuticals Limited
―